Switzerland’s Galderma lifts full-year guidance after H1 sales jump

ZURICH, July 23 (Reuters) – Swiss skincare firm Galderma (GALD.S), on Thursday reported a ​24.6% jump in sales in ‌the first half of the year and nudged up its full-year net ​sales growth guidance, citing ​double-digit growth in international markets and ⁠the U.S.
First-half sales rose to $3.13 ​billion, and the company now ​expects net sales to grow 19-21% this year from a previous target of ​17-20%.
The Zug-based company said it ​had registered double-digit growth in both international ‌markets ⁠and the United States as well as in all product categories, chiefly driven by volume ​and complemented ​by favourable ⁠mix.
Galderma said its full-year guidance factors in manageable ​exposure to announced U.S. ​tariffs, ⁠along with the ability to absorb potential consumer demand deterioration in ⁠the ​second half, given ​a volatile political and macroeconomic environment.

Writing by ​Dave Graham, Editing by Linda Pasquini.

Share this post :

Facebook
Twitter
LinkedIn
Pinterest

Create a new perspective on life

Your Ads Here (365 x 270 area)
Latest News
Categories

Subscribe our newsletter

Purus ut praesent facilisi dictumst sollicitudin cubilia ridiculus.